Polaris Venture Partners Founders' Fund V, L.P., 10% Owner at T2 Biosystems, Inc. (TTOO), sold 44,997 shares at $16.23 ($716K) on 2015-07-07, disclosed to the SEC on 2015-07-07.
Scheduled sale ($716k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.51 | 99 | $2K | 0.2% |
| 2 | $15.51 | 144 | $2K | 0.3% |
| 3 | $15.51 | 282 | $4K | 0.6% |
| 4 | $15.51 | 14,474 | $224K | 31.4% |
| 5 | $15.98 | 99 | $2K | 0.2% |
| 6 | $15.98 | 144 |
| $2K |
| 0.3% |
| 7 | $15.98 | 282 | $5K | 0.6% |
| 8 | $15.98 | 14,474 | $231K | 32.3% |
| 9 | $16.23 | 99 | $2K | 0.2% |
| 10 | $16.23 | 144 | $2K | 0.3% |
| 11 | $16.23 | 282 | $5K | 0.6% |
| 12 | $16.23 | 14,474 | $235K | 32.8% |
| Total | $15.91 avg | 44,997 | $716K | 100% |
| Filing → |
| TTOO | SELL | 2015-06-24 | $546K | — | Filing → |
| OCUL | SELL | 2015-02-04 | $14.8M | — | Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |